Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1828 3
1834 1
1850 1
1851 2
1861 2
1867 1
1869 1
1879 1
1883 1
1891 1
1896 2
1897 1
1898 1
1903 1
1907 2
1908 1
1910 3
1912 4
1913 2
1914 1
1915 2
1916 2
1917 1
1918 2
1919 1
1920 2
1921 1
1922 2
1923 2
1924 2
1925 3
1926 3
1927 2
1928 5
1929 3
1930 1
1931 5
1932 6
1933 3
1934 9
1935 2
1936 4
1937 3
1938 4
1939 4
1943 4
1944 7
1945 239
1946 814
1947 917
1948 1037
1949 884
1950 1382
1951 1832
1952 2117
1953 2159
1954 2309
1955 2336
1956 2302
1957 2282
1958 2143
1959 2156
1960 2146
1961 2267
1962 2675
1963 3657
1964 4574
1965 4026
1966 3884
1967 4680
1968 5195
1969 5389
1970 5406
1971 5717
1972 5809
1973 5593
1974 6152
1975 6200
1976 6055
1977 6388
1978 6276
1979 6498
1980 6360
1981 6504
1982 6957
1983 7232
1984 7764
1985 8151
1986 8423
1987 8414
1988 8694
1989 9430
1990 9563
1991 9376
1992 9324
1993 10314
1994 10459
1995 10534
1996 10936
1997 11277
1998 11608
1999 11735
2000 12655
2001 13065
2002 13824
2003 14418
2004 15104
2005 16847
2006 17657
2007 18842
2008 20061
2009 20916
2010 22634
2011 24112
2012 25302
2013 26372
2014 27459
2015 27744
2016 27798
2017 28355
2018 28531
2019 26749
2020 13164
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

699,176 results
Results by year
Filters applied: . Clear all
Page 1
Myeloma and Bone Disease.
Panaroni C, Yee AJ, Raje NS. Panaroni C, et al. Curr Osteoporos Rep. 2017 Oct;15(5):483-498. doi: 10.1007/s11914-017-0397-5. Curr Osteoporos Rep. 2017. PMID: 28861842 Review.
RECENT FINDINGS: The imbalance between bone regeneration and bone resorption underlies the pathogenesis of osteolytic bone disease. ...Although tremendous progress has been made, MM remains an incurable disease. Novel agents targeting bone
RECENT FINDINGS: The imbalance between bone regeneration and bone resorption underlies the pathogenesis of osteolytic bone
Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences.
Chinoy A, Mughal MZ, Padidela R. Chinoy A, et al. Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F560-F566. doi: 10.1136/archdischild-2018-316330. Epub 2019 May 11. Arch Dis Child Fetal Neonatal Ed. 2019. PMID: 31079069 Review.
Metabolic bone disease of prematurity (MBDP) is characterised by skeletal demineralisation, and in severe cases it can result in fragility fractures of long bones and ribs during routine handling. ...Postnatally, it is difficult to maintain a comparable intake of mi …
Metabolic bone disease of prematurity (MBDP) is characterised by skeletal demineralisation, and in severe cases it can result …
Bone Disease after Kidney Transplantation.
Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A. Bouquegneau A, et al. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1282-96. doi: 10.2215/CJN.11371015. Epub 2016 Feb 15. Clin J Am Soc Nephrol. 2016. PMID: 26912549 Free PMC article. Review.
There is a broad spectrum of often overlapping bone diseases seen after transplantation, including osteoporosis as well as persisting high- or low-turnover bone disease. ...Management is complex, because noninvasive tools, such as imaging and bone
There is a broad spectrum of often overlapping bone diseases seen after transplantation, including osteoporosis as well as per …
Mineral and Bone Disease in Kidney Transplant Recipients.
Altman AM, Sprague SM. Altman AM, et al. Curr Osteoporos Rep. 2018 Dec;16(6):703-711. doi: 10.1007/s11914-018-0490-4. Curr Osteoporos Rep. 2018. PMID: 30390201 Review.
RECENT FINDINGS: The pathophysiology of post-transplant disease is unique, secondary to underlying pre-transplant mineral and bone disease, immunosuppression, and changing kidney function. ...Patients with mineral and bone disease after kidney t …
RECENT FINDINGS: The pathophysiology of post-transplant disease is unique, secondary to underlying pre-transplant mineral and bone
Impact of bone disease and pain in thalassemia.
Piga A. Piga A. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):272-277. doi: 10.1182/asheducation-2017.1.272. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222266 Free PMC article. Review.
Thalassemia bone disease (TBD) is unique: all aspects, from bone anatomy and bone quality to mineral density, may be affected, with important morbidity including osteoporosis, fractures, spinal deformities, nerve compression, and pain. ...Pain, related …
Thalassemia bone disease (TBD) is unique: all aspects, from bone anatomy and bone quality to mineral density, ma …
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.
Yee AJ, Raje NS. Yee AJ, et al. Future Oncol. 2018 Feb;14(3):195-203. doi: 10.2217/fon-2017-0403. Epub 2017 Oct 20. Future Oncol. 2018. PMID: 29052442 Review.
Bone disease is a major source of morbidity, and half of patients with bone involvement develop skeletal-related events such as pathological fractures or cord compression requiring surgery and/or radiation. ...Osteoclast inhibition with bisphosphonates such a
Bone disease is a major source of morbidity, and half of patients with bone involvement develop skeletal-related events
Management of multiple myeloma bone disease: impact of treatment on renal function.
Kanellias N, Gavriatopoulou M, Terpos E, Dimopoulos MA. Kanellias N, et al. Expert Rev Hematol. 2018 Nov;11(11):881-888. doi: 10.1080/17474086.2018.1531702. Epub 2018 Oct 20. Expert Rev Hematol. 2018. PMID: 30285492 Review.
Bone disease (BD) is one of the most common features of multiple myeloma. Seventy to eighty percent of patients at diagnosis present with lytic lesions which may lead to skeletal-related events. Areas covered: The aim of this review is to present the possible advers
Bone disease (BD) is one of the most common features of multiple myeloma. Seventy to eighty percent of patients at diagnosis p
Biology and treatment of myeloma related bone disease.
Terpos E, Christoulas D, Gavriatopoulou M. Terpos E, et al. Metabolism. 2018 Mar;80:80-90. doi: 10.1016/j.metabol.2017.11.012. Epub 2017 Nov 23. Metabolism. 2018. PMID: 29175022 Review.
Myeloma bone disease (MBD) is the most common complication of multiple myeloma (MM), resulting in skeleton-related events (SREs) such as severe bone pain, pathologic fractures, vertebral collapse, hypercalcemia, and spinal cord compression that cause signific …
Myeloma bone disease (MBD) is the most common complication of multiple myeloma (MM), resulting in skeleton-related events (SRE …
Renal Osteodystrophy-Time for Common Nomenclature.
Ott SM. Ott SM. Curr Osteoporos Rep. 2017 Jun;15(3):187-193. doi: 10.1007/s11914-017-0367-y. Curr Osteoporos Rep. 2017. PMID: 28466454 Review.
PURPOSE OF REVIEW: The term renal osteodystrophy has been used to describe a wide variety of bone problems facing patients with chronic kidney disease (CKD). ...RECENT FINDINGS: Bone disease resulting from CKD was first noticed in 1890. The term "renal …
PURPOSE OF REVIEW: The term renal osteodystrophy has been used to describe a wide variety of bone problems facing patients with chron …
New diagnostic modalities and emerging treatments for neonatal bone disease.
Borg SA, Bishop NJ. Borg SA, et al. Early Hum Dev. 2018 Nov;126:32-37. doi: 10.1016/j.earlhumdev.2018.08.014. Epub 2018 Sep 3. Early Hum Dev. 2018. PMID: 30190174 Free article. Review.
Bone disease in the neonatal period has often been regarded as an issue affecting premature infants, or a collection of rare and ultra-rare disorders that most neonatologists will see only once or twice each year, or possibly each decade. ...This paper provides an u
Bone disease in the neonatal period has often been regarded as an issue affecting premature infants, or a collection of rare a
699,176 results
Jump to page
Feedback